Collaboration pairs PerkinElmer’s ICP-MS/MS and LC-MS/MS technologies with Covalent’s failure analysis expertise to help manufacturers pinpoint the root causes of material failure and performance degradation. SHELTON, Conn. and SUNNYVALE, Calif. — PerkinElmer and Covalent today announced a strategic collaboration to provide advanced analytical instrumentation and analysis services that address the growing complexity of failure analysis […]

Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation  Highly Qualified, Independent and Accountable Board Has Taken Decisive Action to Advance Stockholders’ Best Interests Board Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: […]

Seer’s particle-based proteomics IP withstands challenges in both Europe and the United States REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property portfolio protecting its proprietary nanoparticle protein enrichment technology. These milestones underscore Seer’s […]

The agreement establishes a framework for evaluating materials and potential calibration products based on Polymer Factory’s proprietary SpheriCal® technology platform. Under the agreement, the parties will explore selected product concepts and application areas within analytical instrumentation and mass spectrometry. SpheriCal® is Polymer Factory’s patented dendritic polymer technology developed to provide highly defined calibration standards for […]

WASHINGTON, D.C. – At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics. During the ASM 2026 meeting, Bruker showcases the expanded clinical capabilities of […]

The Agreement will bring Aurora Series® XS columns and the HeatSync™ ecosystem to SCIEX’s global commercial channels for ZenoTOF 7600, 7600+, and 8600 systems. San Diego, CA / Melbourne, Australia – IonOpticks, the global leader in advanced nano-LC chromatography for proteomics, and SCIEX, a Danaher company and leader in life science analytical technologies, today share the details […]

SANTA CLARA, Calif. — Agilent Technologies Inc. and Sound Analytics, LLC, today announced a collaboration to deliver an integrated liquid chromatography–triple quadrupole mass spectrometry (LC/MS) workflow designed to support drug metabolism and pharmacokinetics (DMPK) laboratories in biopharma and pharmaceutical research. The joint solution combines Agilent’s 1290 Infinity III Liquid Chromatography system and 6495D triple quadrupole […]

San Diego—ASMS 2026—Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS–based proteomics for research and pharmaceutical drug development. Success is materialized through ease of use and simplicity of comprehensive, standardized workflow solutions meeting today’s analytical requirements. The introduction of Evokit™ sample preparation kits and the Evosep™ Lupo™ Sample Preparation […]

Spectronaut 21 (DIA) and SpectroMine 6 (DDA): cloud-enabled processing, increased identifications, enhanced PTM identification and site localization confidence, improved ion mobility metrics, and open search capabilities for detection of rare modifications Collaboration with SISCAPA Assay Technologies (SAT): qualification of ultrasensitive targeted protein assays for clinical research, including UBE3A quantification in CSF for monitoring of Angelman […]

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. 50% extended upper mass range and comprehensive suite of structural tools advance the development of next-generation biotherapeutics. Integrated MALDI XS and DESI XS imaging with high-resolution ion mobility enables direct […]